Ibandronate is a medicine that is prescribed to prevent and treat osteoporosis in postmenopausal women. This eMedTV resource describes in detail how the drug works, explains when and how it should be taken, and lists possible side effects.
Possible side effects of ibandronate include vomiting, weakness, and headache. This segment of the eMedTV library lists common side effects seen in clinical studies and describes potentially serious problems that may require medical attention.
Ibandronate is used for the treatment and prevention of osteoporosis in postmenopausal women. This eMedTV page further explores what the drug is used for, explains whether it can be used in children, and lists possible "off-label" ibandronate uses.
For monthly treatment with ibandronate, dosing usually starts at 150 mg. This article from the eMedTV Web site also offers dosage recommendations for the injectable form of ibandronate, as well as for those who take the drug on a daily basis.
Aspirin, products containing calcium, and teriparatide may cause drug interactions with ibandronate. This eMedTV segment lists other drugs that may lead to ibandronate interactions and describes the potential effects of combining these medicines.
Osteonecrosis of the jaw is a rare but possible complication that may occur with the use of ibandronate. This eMedTV resource contains more precautions and warnings with ibandronate, including information on who should not take the drug.
| Referring Pages | Articles |
